Device
Bulbicam
Bulbicam is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completed
Validation of Bulbicam Used on Patient Suffering From Diabetes Without Retinopathy
NCT06973694
completed
Validation of Bulbicam for DR- and AMD-patients
NCT05441072
completed
Validation of Bulbicam for Parkinson- and Ataxia-patients
NCT05680571
completed
Bulbicam Validation on Glaucoma- and Cataract Patients
NCT05449041
Clinical Trials (4)
Showing 4 of 4 trials
NCT06973694
Validation of Bulbicam Used on Patient Suffering From Diabetes Without Retinopathy
NCT05441072
Validation of Bulbicam for DR- and AMD-patients
NCT05680571
Validation of Bulbicam for Parkinson- and Ataxia-patients
NCT05449041
Bulbicam Validation on Glaucoma- and Cataract Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4